000 01328 a2200373 4500
005 20250517015325.0
264 0 _c20150909
008 201509s 0 0 eng d
022 _a1177-8881
024 7 _a10.2147/DDDT.S67682
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZhang, Ling
245 0 0 _aTreatment of alarming head and neck infantile hemangiomas with interferon-α2a: a clinical study in eleven consecutive patients.
_h[electronic resource]
260 _bDrug design, development and therapy
_c2015
300 _a723-7 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntineoplastic Agents
_xadverse effects
650 0 4 _aFemale
650 0 4 _aHead and Neck Neoplasms
_xdrug therapy
650 0 4 _aHemangioma
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aInfant
650 0 4 _aInterferon alpha-2
650 0 4 _aInterferon-alpha
_xadverse effects
650 0 4 _aMale
650 0 4 _aRecombinant Proteins
_xadverse effects
650 0 4 _aTime Factors
650 0 4 _aTreatment Outcome
650 0 4 _aTumor Burden
700 1 _aZheng, Jia Wei
700 1 _aYuan, Wei En
773 0 _tDrug design, development and therapy
_gvol. 9
_gp. 723-7
856 4 0 _uhttps://doi.org/10.2147/DDDT.S67682
_zAvailable from publisher's website
999 _c24620521
_d24620521